Cargando…
Effects of RAS inhibitors on all-site cancers and mortality in the Hong Kong diabetes surveillance database (2002-2019)
BACKGROUND: Cancer is replacing cardiovascular-disease as a leading cause of death in type 2 diabetes (T2D). The association of RAS-inhibitors (RASi) and cancer, including differences between angiotensin-converting-enzyme-inhibitor (ACEi) and angiotensin-receptor-blocker (ARBs) as well as their asso...
Autores principales: | Yang, Aimin, Wu, Hongjiang, Lau, Eric S.H., Shi, Mai, Fan, Baoqi, Kong, Alice Pik-Shan, Ma, Ronald Ching-Wan, Luk, Andrea On-Yan, Chan, Juliana Chung-Ngor, Chow, Elaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399959/ https://www.ncbi.nlm.nih.gov/pubmed/35970023 http://dx.doi.org/10.1016/j.ebiom.2022.104219 |
Ejemplares similares
-
The role of age on the risk relationship between prediabetes and major morbidities and mortality: Analysis of the Hong Kong diabetes surveillance database of 2 million Chinese adults
por: Zhang, Xinge, et al.
Publicado: (2022) -
Glucose-lowering drug use, glycemic outcomes, and severe hypoglycemia: 18-Year trends in 0·9 million adults with Diabetes in Hong Kong (2002–2019)
por: Yang, Aimin, et al.
Publicado: (2022) -
Trends in kidney failure and kidney replacement therapy in people with diabetes in Hong Kong, 2002-2015: A retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2021) -
Trends in diabetes-related complications in Hong Kong, 2001–2016: a retrospective cohort study
por: Wu, Hongjiang, et al.
Publicado: (2020) -
Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong
por: Wu, Hongjiang, et al.
Publicado: (2023)